Baker Heart And Diabetes Institute

South Yarra, VIC

UEI
URBPDSVMLCE6
CAGE
Z0RL0
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Non-Profit Organization
Entity structure
International Organization
SAM.gov registration date
Physical address
75 Commercial Rd, South Yarra VIC 3141, Australia
Website
baker.edu.au
Founded
1926
Employees
251-1K
Estimated annual revenue
$50M-$100M
Industry
  1. Consumer Discretionary
  2. Diversified Consumer Services
  3. Education Services
  4. Education
SIC code
82 Educational Services

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Trends in the incidence of young onset type 2 diabetes 75D30121P11718 CDC Pittsburgh $119,000
6M19 HHSD2002017M95531P CDC Pittsburgh $149,893
Global and country-specific rates and trends of incidence of type 2 diabeties HHSD2002016M92119P CDC Pittsburgh $147,470

Grant subawards

Prime recipient Prime award Amount Awarded
George Washington University (The) Epigenetic mechanisms of HAND pathogenesis R21NS137986 $71,609
University Of Texas Health Science Center At Houston Dr. Peter Meikle, MPI, and his team will be responsible for profiling samples on the Baker lipidomics platform (platform described below) at the Baker Heart &… R01AG081322 $228,040
Duke University Lipidomic technology developed at Baker Heart and Diabetes Institute offers rapid analysis of large clinical cohorts: At the Metabolomics Laboratory, PI… U01AG061359 $535,468
George Washington University (The) Epigenetic mechanisms of HAND pathogenesis R21NS137986 $55,000
George Washington University (The) Epigenetic mechanisms of HAND pathogenesis R21NS137986 $109,291

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Baker Heart And Diabetes Institute, doing business as Baker Institute, is an independent, internationally renowned medical research facility focused on laboratory, community, and clinical studies related to heart disease and diabetes.

Through a recent prime federal contract award from the Centers for Disease Control and Prevention, Baker Institute conducted research on trends in the incidence of young onset Type 2 diabetes, providing a final report in August 2022.

Baker Institute has also provided various research services as a subawardee on federal grants. These services have included lipidomic profiling of samples from Alzheimer's disease studies, bioinformatic analysis of lipidomics data, and development of single-chain antibody drugs targeting thrombosis. The grants supporting this work were awarded by the National Institutes of Health, Department of Defense, and other federal agencies to prime recipients such as Duke University, George Washington University, and Beth Israel Deaconess Medical Center.

Baker Institute's subawards often leverage its expertise in advanced lipidomic platforms to rapidly profile lipid species in clinical cohorts. This technology has been used to explore associations between plasma lipids and diseases like obesity, Type 2 diabetes, coronary artery disease, and Alzheimer’s. The subawards also occasionally fund Baker Institute to provide specialized biologics research and bioinformatic capabilities to collaborative grant projects.

Quick answers

Is Baker Heart And Diabetes Institute registered in SAM.gov?

Yes. Baker Heart And Diabetes Institute's SAM.gov registration is active through November 24, 2026.

What is Baker Heart And Diabetes Institute's most recent federal award?

Baker Heart And Diabetes Institute's most recent federal contract award is Trends in the incidence of young onset type 2 diabetes (75D30121P11718), from CDC Pittsburgh, on July 9, 2021.

On GovTribe

See Baker Heart And Diabetes Institute's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors